---
skill: earnings-preview
plugin: equity-research@claude-for-financial-services
slash_command: /earnings-preview
test_name: Telefónica (TEF.MC) — Q1 2026
print_date: 14 May 2026 (verified, Yahoo Finance)
v2: anchored on facts pack (file 14)
as_of: 2026-05-06 (8 days ahead of print)
real_deliverable: 4-6 page DOCX or markdown digest
---

# Telefónica Q1 2026 — earnings preview (v2)

**Reports:** Wednesday 14 May 2026, before market open (verified)
**Conference call:** typically 14:00 CET (10:00 BST) on the day
**Stance into print:** HOLD, balanced setup — first Transform & Grow execution check

## Strategic context

This is the first quarterly print under the Transform & Grow plan announced 4 November 2025. The market will scrutinise three things:

1. Is Spain operationally delivering on the "best KPIs since 2018" trajectory established at FY25 results?
2. Is capex tracking toward the ~12% / sales target for 2026?
3. Is the FCF run-rate consistent with the €3.0bn 2026 guidance?

Q4 2025 ran at €9,174M revenue (+1.3%) and €3,198M adjusted EBITDA (+2.8%). Q1 2026 needs to be in a similar zone for the +1.5-2.5% group guidance to look comfortable.

## Consensus expectations (consensus pull approximate)

| Metric | Q1 2026 consensus (est.) | Q1 2025 actual | YoY (constant) |
|---|---|---|---|
| Revenue (€m) | ~8,900 | ~8,800 | flat to +1% |
| Adjusted EBITDA (€m) | ~3,000 | ~2,950 | +1.5–2% |
| OIBDA margin | ~33.7% | ~33.5% | +20bps |
| Capex / sales | ~12% | ~12.5% | -50bps |
| FCF (€m) | ~700 | ~600 | growing |

*Note: "Q1 2025 actual" is approximated from full-year disclosure and quarterly slides; not all line items are publicly disclosed at the quarterly cadence. Consensus pull is approximate; a production preview would refresh from Bloomberg/FactSet 24–48h before publication.*

## Top 5 things to watch

### 1. Spain mobile ARPU sequential — *most important*
The "best KPIs since 2018" claim from FY25 needs to extend into Q1 2026. Sequential ARPU stable-to-growing = thesis Pillar 1 confirmed. Any sequential deterioration = a leg of the thesis weakens. CNMC monthly portability reports for Jan–Mar 2026 will give an advance read by the time of the call.

### 2. Capex / sales pacing
Full-year 2026 guidance is ~12% / sales. Q1 historically runs slightly above the full-year run-rate (back-loaded fibre & spectrum in H2). If Q1 2026 shows capex/sales >13%, the FCF guidance becomes harder to defend.

### 3. FCF run-rate vs €3.0bn 2026 guidance
Each quarter should approximate ~€750m FCF on a smoothed basis. Q1 typically lighter (working capital seasonality). A Q1 FCF print of ~€500-700m keeps the 2026 guidance alive; below €400m and the Street will start questioning the €3bn target.

### 4. VMO2 / UK strategic commentary
VMO2 lock-up expires June 2026. This Q1 call is the last formal opportunity for Murtra to set expectations before the constraint lifts. Any update on third-party investor interest (STC mentioned in press) materially affects the SOTP component of valuation.

### 5. Mexico exit final closing details
Sold to Melisa Acquisition (announced Q1 2026 per TelcoTitans). Closing mechanics, proceeds amount, deconsolidation timing all matter for the Hispam segment line in 2026 actuals.

## Bull / base / bear scenarios

**Bull (~25% probability)**
- Spain ARPU +1% sequential
- Q1 FCF €700m+, full-year guidance reaffirmed or upgraded
- VMO2 strategic clarity (third-party investor pipeline named)
- STC engagement signal (board representation request, partnership intent)

Stock reaction: +5–8%, multiple re-rates toward 5.0x EV/EBITDA

**Base (~55% probability)**
- Spain ARPU stable-to-modestly positive
- Q1 FCF in line, full-year guidance reaffirmed
- VMO2 commentary "ongoing", no specific update
- STC quiet

Stock reaction: -2% to +2%, multiple stable around 4.5x

**Bear (~20% probability)**
- Spain ARPU sequential decline
- Q1 capex elevated, FCF light
- Guidance not reaffirmed (any caveats)

Stock reaction: -5–8%, multiple compresses toward 4.0x

## Trade construction

- **Holding through print** — thesis is HOLD/+8%, balanced setup. No need to size up or trim ahead of binary event.
- **Pair watch** — DTE prints same week; relative performance tells you whether sector or stock-specific moves the price.
- **Listen for VMO2 specifics** — the most asymmetric upside catalyst in the calendar.

## Recent estimate revisions (illustrative)

| Date | Source | Action | Note |
|---|---|---|---|
| Apr 2026 | Goldman | Maintain Buy €4.50 | T&G execution pacing |
| Apr 2026 | Berenberg | Maintain Hold €3.50 | Balanced |
| Mar 2026 | New Street | Maintain Reduce €2.60 | Multiple compression risk |

Median PT: €3.90 | Range: €2.60 – €5.00 | Consensus: Neutral (3B/14H/6S)

## What changed v1 → v2

| Element | v1 | v2 |
|---|---|---|
| Reporting date | "Thursday 8 May 2026" | **Wednesday 14 May 2026** (verified) |
| Strategic context | "Pillar 1 of bull thesis being tested" | **"First Transform & Grow execution check; FY25 set 'best KPIs since 2018' bar"** |
| Consensus tone | "Median Buy" | **Neutral with 14 Holds (verified MarketBeat)** |
| Bull case multiple | "EV/EBITDA re-rates toward 4.5x" | "**5.0x"** (since 4.5x is roughly current) |
| Dividend guard | Implicit (€0.30 maintained) | **Removed — dividend already cut for 2026; capital allocation reset is the point** |
| Watch items | 5 listed; #5 was STC engagement | 5 listed; **#4 is now VMO2 lock-up expiry timing** |

## Caveat

A real earnings preview pulls live consensus from Bloomberg/FactSet 24–48 hours before publication. The exact Q1 2026 consensus figures here are approximations — a production version would refresh on the day before print. Verified items (reporting date 14 May, sell-side ratings 3B/14H/6S, FY25A baseline figures) are anchored to the v2 facts pack.